Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Aprepitant (compound)
Most Correlated Studies
- Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- Effects of aprepitant in daily administrations of low-dose cisplatin].
- Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting …
- Gastroparesis-associated refractory nausea treated with aprepitant.
- Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving …
- Use of high-dose cisplatin with aprepitant in an outpatient setting.
Most Relevant Clinical Trials
- Efficacy of Aprepitant (Emend®) in Children
- Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents
- Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis
- Aprepitant Effects on Oxycodone Response
- A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) P…
